Next Article in Journal
Pesticide Removal from Aqueous Solutions by Adding Salting Out Agents
Next Article in Special Issue
Aberrant Expression of Posterior HOX Genes in Well Differentiated Histotypes of Thyroid Cancers
Previous Article in Journal
Overexpression of Ferredoxin, PETF, Enhances Tolerance to Heat Stress in Chlamydomonas reinhardtii
Previous Article in Special Issue
Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions
Open AccessReview

MicroRNA-Regulated Pathways in Hematological Malignancies: How to Avoid Cells Playing Out of Tune

by 1,*,† and 2,*,†
1
Department of Biology and Biotechnology "Charles Darwin", Sapienza University of Rome, Rome 00185, Italy
2
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina 04100, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2013, 14(10), 20930-20953; https://doi.org/10.3390/ijms141020930
Received: 31 July 2013 / Revised: 3 October 2013 / Accepted: 10 October 2013 / Published: 18 October 2013
(This article belongs to the Special Issue Molecular Bases of Cancer Research)
The coordinated expression and interplay among lineage specific transcription factors and microRNAs contribute to the regulation of gene expression and determination of cell specificity. In hematopoietic stem cells (HSCs), unique combinations of transcription factors largely control growth and maturation of different blood cell lineages through cooperative regulation of specific target genes. MicroRNAs provide an additional level of control beyond transcription factors. By acting as regulators of crucial lineage-specific genetic programs, microRNAs direct early multipotential progenitor cells to adopt a certain cell fate program. Thus, alteration of specific microRNA levels may affect proliferation, differentiation and genetic stability of HSCs, contributing to the onset of myeloproliferative disorders and leukemia. The major aim of this review is to highlight the critical role of microRNA-regulated pathways during the establishment and progression of hematological malignancies, with a particular attention to leukemia, lymphomas and myelodysplastic syndromes. This will give us the opportunity to discuss the potential use of microRNA-based therapeutic approaches in these diseases. MicroRNAs are indeed emerging as relevant tools to improve the efficacy of currently used therapeutic protocols. View Full-Text
Keywords: microRNA; leukemia; lymphoma microRNA; leukemia; lymphoma
MDPI and ACS Style

Fatica, A.; Fazi, F. MicroRNA-Regulated Pathways in Hematological Malignancies: How to Avoid Cells Playing Out of Tune. Int. J. Mol. Sci. 2013, 14, 20930-20953. https://doi.org/10.3390/ijms141020930

AMA Style

Fatica A, Fazi F. MicroRNA-Regulated Pathways in Hematological Malignancies: How to Avoid Cells Playing Out of Tune. International Journal of Molecular Sciences. 2013; 14(10):20930-20953. https://doi.org/10.3390/ijms141020930

Chicago/Turabian Style

Fatica, Alessandro; Fazi, Francesco. 2013. "MicroRNA-Regulated Pathways in Hematological Malignancies: How to Avoid Cells Playing Out of Tune" Int. J. Mol. Sci. 14, no. 10: 20930-20953. https://doi.org/10.3390/ijms141020930

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop